Zealand Pharma
714
DKK
-1.92 %
ZEAL
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
18 following
-1.92%
-0.21%
-1.79%
-9.39%
-19.78%
+100.79%
+392.07%
+210.7%
+798.11%
Zealand Pharma is a biotechnology company. Particular focus is found in the development of drugs for the treatment of diabetes and various intestinal diseases. The company has a varied product portfolio with separate brands that are sold on a global level. The largest business is in the Nordic market. Zealand Pharma was founded in 1997 and is headquartered in Söborg, Denmark.
Read moreMarket cap
50.71B DKK
Turnover
166.18M DKK
Revenue
342.79M
EBIT %
-166.94 %
P/E
-
Dividend yield-%
-
Financial calendar
20.2
2025
Annual report '24
8.5
2025
Interim report Q1'25
14.8
2025
Interim report Q2'25
ShowingAll content types
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools